# Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee

> **NCT03271229** · PHASE2 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **BIOLOGICAL:** Concentrated Bone Marrow Aspirate (BMAC)
- **BIOLOGICAL:** Platelet-Rich Plasma (PRP)

## Key facts

- **NCT ID:** NCT03271229
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271229, "Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03271229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*